Pharma’s TV buys show it’s loath to change channels

Drugmakers ramped up TV investment by 1.6%, to $5.8 billion, in 2022. Industry-wide, direct-to-consumer spending rose 5.6%, to $7.6 billion from $7.2 billion in 2021, according to Nielsen Ad Intel, which tracks media investment.